Meet Our Featured Speakers

European mRNA Conference 2026 welcomes presentation proposals focusing on the following key topics:

• Future of mRNA-based therapeutics in infectious diseases and other areas
• Latest advancements in mRNA formulation and delivery technologies 
• Breakthrough research on mRNA medicines and oligonucleotide therapeutics 
• Data-driven strategies using AI and ML in mRNA therapeutic design
• Manufacturing challenges in global mRNA vaccine production 
• Regulatory and compliance considerations in mRNA clinical development

European mRNA Conference 2026 provides a timely platform to address the challenges associated with emerging technologies in developing next-generation mRNA therapeutics, innovative formulations, and clinical advancements.

European mRNA Conference 2026 will provide professionals across relevant disciplines with the opportunity to share their achievements and exchange perspectives. The event will emphasise networking and relationship-building, encouraging dialogue on technical expertise within the pharmaceutical and biotechnology industries. Attendees will also have the opportunity to engage with leading biotechnology and pharmaceutical producers and gain valuable insights into emerging technologies, including siRNA, microRNA, and advanced approaches in mRNA therapeutics.

Presentations focusing on new vaccine technologies, siRNA, microRNA, clinical trials, manufacturing processes, clinical case studies, and new market data for current and emerging vaccination initiatives will form the core of this conference, alongside other relevant topics.

We invite you to take part in what promises to be a highly productive experience, offering the chance to collaborate with industry experts in this rapidly evolving market.